Trial Profile
Efficacy and safety of edoxaban for lower-extremity venous thrombosis in patients with lung cancer - Prospective observational study-
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2022
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Venous thrombosis
- Focus Therapeutic Use
- 29 Oct 2022 Status changed from recruiting to discontinued.
- 28 Apr 2017 New trial record